GlaxoSmithKline saw first-quarter profit drop 30%, a week after it announced a series of multibillion-dollar asset swaps with Novartis to bolster its consumer health and vaccines businesses.
via WSJ.com: US Business http://ift.tt/1lyASeW
via WSJ.com: US Business http://ift.tt/1lyASeW
Nessun commento:
Posta un commento